Company

StemSelect

4, rue Pierre Fontaine – Campus 3
F-91058 Evry Cedex

Phone: +33(0)6 80 76 26 51
E-mail: amarti@stemselect.com

Aurélien MARTI : CEO

Site Web >

Booster #Medical device #Health&well-being

Stem cells
Cell therapy
Regenerative therapy

Field of activity

Our aim is to pave the way for a general access to cell therapy. We are developing a rapid isolation method of stem cells derived from one’s own fat tissue.

BACKGROUND

We came up with our technology among colleagues at Johns Hopkins University in the United States. We are now developing and optimizing our patent protected innovations in the Paris region.

DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY

Our device isolates stem cells from a patient’s liposuction sample. Our special feature is that we do not use enzymes or other products that could alter cells and we do so without sacrificing purity. Our process is completely mechanical and allows us to create a product ready to be injected into the same patient for therapeutic purposes.

FURTHER INFORMATION

Patents: 2
2 staff members
Fund raising: €500,000
Strengths
Innovative technique that can quickly deliver cell therapy safely and at affordable prices.

Innovation assets
Innovative and safe technology with a processing time lasting less than an hour to isolate stem cells from fat.